Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective. Issue 4 (24th December 2021)
- Record Type:
- Journal Article
- Title:
- Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective. Issue 4 (24th December 2021)
- Main Title:
- Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective
- Authors:
- Hariparsad, Niresh
Ramsden, Diane
Taskar, Kunal
Badée, Justine
Venkatakrishnan, Karthik
Reddy, Micaela B.
Cabalu, Tamara
Mukherjee, Dwaipayan
Rehmel, Jessica
Bolleddula, Jayaprakasam
Emami Riedmaier, Arian
Prakash, Chandra
Chanteux, Hugues
Mao, Jialin
Umehara, Kenichi
Shah, Kushal
De Zwart, Loeckie
Dowty, Martin
Kotsuma, Masakatsu
Li, Mengyao
Pilla Reddy, Venkatesh
McGinnity, Dermot F.
Parrott, Neil - Abstract:
- Abstract : The International Consortium for Innovation and Quality (IQ) Physiologically Based Pharmacokinetic (PBPK) Modeling Induction Working Group (IWG) conducted a survey across participating companies around general strategies for PBPK modeling of induction, including experience with its utility to address various questions, regulatory interactions, and regulatory acceptance. The results highlight areas where PBPK modeling is used with high confidence and identifies opportunities where confidence is lower and further evaluation is needed. To enhance the survey results, the PBPK‐IWG also collected case studies and analyzed recent literature examples where PBPK models were applied to predict CYP3A induction‐mediated drug‐drug interactions. PBPK modeling of induction has evolved and progressed significantly, proving to have great potential to accelerate drug discovery and development. With the aim of enabling optimal use for new molecular entities that are either substrates and/or inducers of CYP3A, the PBPK‐IWG proposes initial workflows for PBPK application, discusses future trends, and identifies gaps that need to be addressed.
- Is Part Of:
- Clinical pharmacology & therapeutics. Volume 112:Issue 4(2022)
- Journal:
- Clinical pharmacology & therapeutics
- Issue:
- Volume 112:Issue 4(2022)
- Issue Display:
- Volume 112, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 112
- Issue:
- 4
- Issue Sort Value:
- 2022-0112-0004-0000
- Page Start:
- 770
- Page End:
- 781
- Publication Date:
- 2021-12-24
- Subjects:
- Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5 - Journal URLs:
- http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗ - DOI:
- 10.1002/cpt.2503 ↗
- Languages:
- English
- ISSNs:
- 0009-9236
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23338.xml